Gastrointestinal Stent Market is anticipated to grow at a CAGR of 5.5%, to reach up to USD 796.8 billion by 2031

The global gastrointestinal stent market was valued at USD 467 million in 2021 and it is anticipated to reach up to USD 796.8 billion by 2031, at a CAGR of 5.5% during the forecast period.

Gastrointestinal (GI) stents are made to provide palliative care for a variety of illnesses that clog the GI tract. The recanalization of gastrointestinal (GI) malignancies and postoperative leak sealing are two important functions of GI stents. Drug-eluting devices, tissue modeling for benign disorders, and GI tract drainage/anastomosis are among more possible uses for GI stents. The rise in gastrointestinal malignancies and other digestive illnesses, changing lifestyles, rising healthcare spending on gastrointestinal treatments, and growing desire for less invasive surgery are all factors contributing to the growth of the global market for gastrointestinal stents.

Read more about Gastrointestinal Stent Market here: https://www.globalinsightservices.com/reports/gastrointestinal-stent-market/

Market Trends and Drivers:

The increase in the incidence of gastrointestinal cancers, IBD, and other digestive diseases is propelling the growth of the market. One of the biggest causes of death in the globe is gastrointestinal cancer. Morbidity and mortality from chronic diseases like esophageal cancer, colorectal cancer, and serious gastrointestinal disorders have sharply increased in recent years. According to the International Agency for Research on Cancer (IARC), gastrointestinal malignancies accounted for 35 percent of all cancer-related fatalities and 26 percent of the global burden of cancer incidence in 2018. The WHO estimates that stomach cancer caused 769,000 deaths worldwide in 2020, whereas gastrointestinal malignancies like colorectal cancer cause 935,000 deaths. 1.93 million new instances of colorectal cancer were detected worldwide in 2020, making it the third most frequent cancer overall.

COVID-19 Impact:

Over 4.4 million people have been afflicted by the coronavirus, which has spread to 215 nations and territories and caused close to 300,000 deaths. The global COVID-19 outbreak has put medical practices of all sizes under a great deal of stress. A worldwide emergency has been caused by the COVID-19 pandemic. The risk of COVID-19 infection is higher for surgeons and patients who visit hospitals for various procedures. All elective procedures in Germany were either canceled or postponed because hospitals there are overflowing with COVID-19 cases. Major hospitals in Germany had to postpone between 40 and 50 percent of their endoscopic treatments.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS10289/

Major limitations on in-person consultations were enacted by numerous nations during the COVID-19 pandemic. As a result, stenting procedures were reduced in hospitals and outpatient clinics, and consultations were conducted via phone consultations, which was the most practical mode of delivery. This has had an impact on how frequently gastrointestinal stents are used in most healthcare settings. For instance, a survey by the Chinese Society of Digestive Endoscopy (CSDE) found that from 3,2 million treatments in 2019 to 1.5 million in 2020, China's GI endoscopic procedures had a considerable decline. Nearly all medical device markets had fully recovered by early 2021 from the pandemic's severe decline in device sales. However, the introduction of the Omicron model could endanger the expansion of sales of medical devices and lead to more cancellations of elective surgeries. The administration of booster doses and the current worldwide vaccination race will, however, lead to a market rebound in the years to come.

Major Players in the Global Gastrointestinal Stent Market:

The key players studied in the global gastrointestinal stent market are Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), Taewoong Medical (South Korea) among others.

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS10289/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.